Nucleotide variation in Foxp3 gene and prognosis of bladder cancer: a case-control study

Nucleotide variation in Foxp3 gene and prognosis of bladder cancer: a case-control study

BackgroundNumerous researches have investigated the correlation between single nucleotide polymorphisms (SNPs) in the transcription factor forkhead box protein 3 (Foxp3) gene and the development of various cancers. However, the relationship of Foxp3 polymorphism and bladder cancer (BC) remain unclea...

Full description

Saved in:

Bibliographic Details
Main Authors:	Qin Li, Yan Zhang, Min Su, Yaping Song, Yanyun Wang, Bin Zhou, Lin Zhang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Oncology
Subjects:	Foxp3 polymorphism prognosis non-muscle-invasive bladder cancer tumor microenvironment
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1506900/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

FOXP3 as a prognostic marker and therapeutic target in immunogenic cell death modulation for clear cell renal cell carcinoma
by: Jian Chen, et al.
Published: (2025-01-01)

Impact of HER2 Expression on the Prognosis of Muscle-Invasive Bladder Cancer Patients Treated with Bladder-Preservation Comprehensive Therapy
by: Yatong Chen, et al.
Published: (2025-01-01)

Bladder-sparing therapy in a case report of huge muscle-invasive bladder IMT treated with 1470 nm diode laser en bloc resection followed by laparoscopic partial cystectomy
by: Junhao Chu, et al.
Published: (2025-02-01)

Evaluating the concordance between Vesical Imaging Reporting and Data System scores and bladder tumor histopathology
by: Hasan Gungor, et al.
Published: (2025-01-01)

A novel bladder cancer surveillance schedule using bladder Cx for patients on annual surveillance
by: Arjun Guduguntla, et al.
Published: (2025-01-01)

Surgical outcomes of a partial or total cystectomy for colorectal cancer invading the urinary bladder
by: Sakiko Nakamori, et al.
Published: (2025-02-01)

The clinical significance of T cell infiltration and immune checkpoint expression in central nervous system germ cell tumors
by: Jiajun Zhou, et al.
Published: (2025-01-01)

Integration of bulk and single-cell RNA-seq reveals prognostic gene signatures in patients with bladder cancer treated with immune checkpoint inhibitors
by: Mina Cho, et al.
Published: (2024-12-01)

Integrated analysis of M2 macrophage-related gene prognostic model and single-cell sequence to predict immunotherapy response in lung adenocarcinoma
by: Meifang Li, et al.
Published: (2025-02-01)

Pan-cancer analysis and single-cell analysis identifies the CENPN as a biomarker for survival prognosis and immunotherapy
by: Nie Zhang, et al.
Published: (2025-01-01)

Risk factors for lymphatic leakage following radical cystectomy and pelvic lymph node dissection in patients with muscle-invasive bladder cancer
by: Zixuan Xue, et al.
Published: (2025-01-01)

Matrix Metalloproteinase-9 is associated with tumor microenvironment remodeling of bladder cancer
by: Fang Fang, et al.
Published: (2025-01-01)

Redefining bladder cancer treatment: innovations in overcoming drug resistance and immune evasion
by: Peng Huang, et al.
Published: (2025-01-01)

Trimodal organ‑preserving treatment of muscle‑invasive bladder cancer
by: A. V. Troianov, et al.
Published: (2023-03-01)

Bioinformatic characterization of STING expression in hematological malignancies reveals association with prognosis and anti-tumor immunity
by: Xiang-mei Wen, et al.
Published: (2025-02-01)

Understanding the long‐term impact of the COVID‐19 pandemic on non‐muscle‐invasive bladder cancer outcomes: 12‐Month follow‐up data from the international, prospective COVIDSurg Cancer study
by: Cameron E. Alexander, et al.
Published: (2024-11-01)

Capecitabine enhances sensitivity to oxaliplatin in advanced gastric cancer and the effects on patients’ FOXP1 and GGT levels
by: Xinyu Guo, et al.
Published: (2025-01-01)

Feasibility of enzalutamide on patients with recurrent non-muscle-invasive bladder cancer with marker tumors: phase I study
by: Takashi Kawahara, et al.
Published: (2025-01-01)

Retrospective, Non-Interventional, Multicenter Study on the Effectiveness and Safety of Intravesical Bacillus Calmette–Guerin in Patients with Non-Muscle-Invasive Bladder Cancer: Real-World Experience from Six Hospital Centers in Greece
by: Panagiotis Angelopoulos, et al.
Published: (2024-12-01)

Treatment preferences of patients with muscle invasive bladder cancer: A discrete choice experiment
by: Liam Mannion, et al.
Published: (2024-11-01)

Prognostic evaluation of non-muscle invasive bladder cancer with P-CRP and its nomogram
by: Junyun Wu, et al.
Published: (2025-02-01)

Reliability of mpMRI in diagnosing cancer prostate following intravesical BCG for bladder cancer
by: Arjun Pon Avudaiappan, et al.
Published: (2024-11-01)

Identification of a novel immunogenic cell death-related classifier to predict prognosis and optimize precision treatment in hepatocellular carcinoma
by: Dongjing Zhang, et al.
Published: (2025-01-01)

COVID-19 impact on bladder cancer treatment
by: Fabrício Kaminagakura, et al.
Published: (2024-01-01)

Clinicopathological study and molecular subtyping of muscle-invasive bladder cancer (MIBC) using dual immunohistochemical (IHC) markers
by: R. Vaithegi, et al.
Published: (2025-01-01)

Development and functional validation of a disulfidoptosis-related gene prognostic model for lung adenocarcinoma based on bioinformatics and experimental validation
by: Tao Shen, et al.
Published: (2025-02-01)

Clinical and molecular response to alpha1‐oleate treatment in patients with bladder cancer
by: Farhan Haq, et al.
Published: (2024-09-01)

Revolutionizing ESCC prognosis: the efficiency of tumor-infiltrating immune cells (TIIC) signature score
by: Haixia Wang, et al.
Published: (2025-01-01)

Indian consensus statements on the management of small renal masses, non‐muscle invasive bladder cancer and high‐risk/locally advanced prostate cancer
by: Simon Hughes, et al.
Published: (2024-11-01)

Identification of SETD4 as an Onco‐Immunological Biomarker Encompassing the Tumor Microenvironment, Prognoses, and Therapeutic Responses in Various Human Cancers
by: Yuyun Zhong, et al.
Published: (2025-01-01)

Comparison of BCG Tokyo172 Strain Induction Therapy Between Low Dose and Standard Dose for Non-Muscle Invasive Bladder Cancer: Intravesical Instillation of BCG Tokyo172 Strain
by: Hideyuki Isobe, et al.
Published: (2025-01-01)

Inflammatory myofibroblastic tumors of the urinary bladder in a 10-year-old male
by: Chen Gong, et al.
Published: (2025-02-01)

Mature Teratoma Combined with Bladder Stones: A Case Report and Literature Review
by: Li A, et al.
Published: (2025-01-01)

The microenvironment cell index is a novel indicator for the prognosis and therapeutic regimen selection of cancers
by: Xian-Yan Yang, et al.
Published: (2025-01-01)

Single-cell sequencing uncovers the mechanistic role of DAPK1 in glioma and its diagnostic and prognostic implications
by: Tian-Hang Yu, et al.
Published: (2025-01-01)

Cost-reduction strategy to culture patient derived bladder tumor organoids
by: Mahsa Mollapour Sisakht, et al.
Published: (2025-02-01)

TUBA1B as a novel prognostic biomarker correlated with immunosuppressive tumor microenvironment and immunotherapy response
by: Juntao Qi, et al.
Published: (2025-02-01)

Novel protein-based prognostic signature linked to immunotherapeutic efficiency in ovarian cancer
by: Shuo-Fu Chen, et al.
Published: (2024-09-01)

The role of LMNB2 as a diagnostic and prognostic biomarker in lung adenocarcinoma
by: Shengshan Xu, et al.
Published: (2025-02-01)

TLR7: A Key Prognostic Biomarker and Immunotherapeutic Target in Lung Adenocarcinoma
by: Feiming Hu, et al.
Published: (2025-01-01)